C
Cora N. Sternberg
Researcher at Cornell University
Publications - 747
Citations - 57991
Cora N. Sternberg is an academic researcher from Cornell University. The author has contributed to research in topics: Prostate cancer & Cancer. The author has an hindex of 92, co-authored 663 publications receiving 48986 citations. Previous affiliations of Cora N. Sternberg include CTO Hospital & North Shore University Hospital.
Papers
More filters
Journal ArticleDOI
Optimal management of metastatic castration-resistant prostate cancer: Highlights from a European Expert Consensus Panel
John M. Fitzpatrick,Joaquim Bellmunt,Karim Fizazi,Axel Heidenreich,Cora N. Sternberg,Bertrand Tombal,Antonio Alcaraz,Amit Bahl,Sergio Bracarda,Giuseppe Di Lorenzo,Eleni Efstathiou,Stephen P. Finn,Sophie D. Fosså,Silke Gillessen,Pirkko-Liisa Kellokumpu-Lehtinen,Frédéric Lecouvet,Stéphane Oudard,Theo M. de Reijke,Craig N. Robson,Maria De Santis,Bostjan Seruga,Ronald de Wit +21 more
TL;DR: Clinicians expert guidance on the implementation of recent advances to improve patient outcome is offered, focusing on the future of prostate cancer care.
Journal ArticleDOI
Pazopanib: Clinical development of a potent anti-angiogenic drug
TL;DR: Pazopanib showed clinical activity in several tumors including renal cell cancer, breast cancer, soft tissue sarcoma, thyroid cancer, hepatocellular cancer and cervical cancer, and was well tolerated with the main side effects being hypertension, fatigue and gastrointestinal disorders.
Journal ArticleDOI
Docetaxel and prednisone with or without lenalidomide in chemotherapy-naive patients with metastatic castration-resistant prostate cancer (MAINSAIL): a randomised, double-blind, placebo-controlled phase 3 trial
Daniel P. Petrylak,Nicholas J. Vogelzang,Nikolay Budnik,Paweł Wiechno,Cora N. Sternberg,Kevin Doner,Joaquim Bellmunt,John M Burke,Maria Ochoa de Olza,Ananya Choudhury,Juergen E. Gschwend,Evgeny Kopyltsov,Aude Flechon,Nicolas van As,Nadine Houede,Debora Barton,Abderrahim Fandi,Ulf Jungnelius,Shaoyi Li,Ronald de Wit,Karim Fizazi +20 more
TL;DR: Overall survival with the combination of lenalidomide, docetaxel, and prednisone was significantly worse than with docetAXel andprednisone for chemotherapy-naive men with metastatic, castration-resistant prostate cancer.
Journal ArticleDOI
Prognostic factors for survival of patients with advanced urothelial tumors treated with methotrexate vinblastine doxorubicin and cisplatin chemotherapy
TL;DR: Analysis of prognostic factors for survival of the first 92 patients was undertaken using the Cox proportional hazards model, and normal alkaline phosphatase and high Karnofsky performance status (KPS) were predominant for long survival.
Journal ArticleDOI
Comparison of the BTA stat test with voided urine cytology and bladder wash cytology in the diagnosis and monitoring of bladder cancer.
Herbert Leyh,Michael Marberger,Pierre Conort,Cora N. Sternberg,Vito Pansadoro,Francesco Pagano,Pierfrancesco Bassi,Laurent Boccon-Gibod,Vincent Ravery,Uwe Treiber,Laura Ishak +10 more
TL;DR: The BTA stat test is considerably more sensitive than cytology in the detection of BC and can replace cytology as an adjunct to cystoscopy in the diagnosis and follow-up of patients with BC.